利润表
HEALTHEQUITY, INC.
HQY
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Jan 31, 2026 2026 FY | Jan 31, 2025 2025 FY | Jan 31, 2024 2023 FY | Jan 31, 2023 2022 FY | Jan 31, 2022 2021 FY | Jan 31, 2021 2020 FY | Jan 31, 2020 2019 FY | Jan 31, 2019 2018 FY | Jan 31, 2018 2017 FY | Jan 31, 2017 2016 FY | Jan 31, 2016 2015 FY | Jan 31, 2015 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
1,313.43 | 1,199.77 | 999.59 | 861.75 | 756.56 | 733.57 | 531.99 | 287.24 | 229.53 | 178.37 | 126.79 | 87.86 |
|
营业成本
|
400.31 | 422.52 | 376.95 | 371.66 | 332.85 | 318.24 | 206.08 | 106.05 | - | - | - | - |
|
毛利润
|
913.12 | 777.26 | 622.64 | 490.09 | 423.71 | 415.33 | 325.91 | 181.19 | 134.92 | 106.36 | 72.60 | 47.97 |
|
营业费用
|
590.66 | 614.93 | 504.94 | 481.03 | 447.94 | 381.32 | 248.90 | 103.52 | 80.50 | 65.14 | 46.46 | 31.10 |
|
研发费用
|
262.51 | 239.51 | 218.81 | 193.38 | 157.36 | 124.81 | 77.58 | 35.06 | 27.39 | 22.38 | 16.83 | 10.50 |
|
销售、一般及行政费用
|
119.93 | 132.26 | 103.66 | 95.63 | 84.38 | 84.49 | 60.56 | 33.04 | 25.11 | 20.15 | 14.11 | 10.62 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
322.46 | 162.33 | 117.70 | 9.06 | -24.24 | 34.01 | 77.01 | 77.67 | 54.42 | 41.21 | 26.14 | 16.87 |
|
营业外收入
|
-45.02 | -46.30 | -42.66 | -47.15 | -42.50 | -29.87 | -33.85 | 1.85 | 2.23 | 1.09 | 0.59 | 1.11 |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
- | - | 55.46 | 48.42 | 36.57 | 34.88 | 24.77 | 0.30 | 0.27 | 0.28 | 0.09 | 0.00 |
|
其他营业外收入/支出
|
12.11 | 14.33 | 12.80 | 1.27 | -5.93 | 5.01 | -9.08 | -1.85 | -2.23 | -1.09 | -0.59 | -1.11 |
|
税前利润
|
277.43 | 116.03 | 75.04 | -38.10 | -66.74 | 4.14 | 43.16 | 75.82 | 52.19 | 40.12 | 25.55 | 15.76 |
|
所得税费用
|
62.23 | 19.33 | 19.33 | -11.95 | -22.45 | -4.69 | 3.49 | 1.92 | 4.83 | 13.74 | 8.94 | 5.60 |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
215.20 | 96.70 | 55.71 | -26.14 | -44.29 | 8.83 | 39.66 | 73.90 | 47.36 | 26.38 | 16.61 | 10.17 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Jan 31, 2026 2026 FY | Jan 31, 2025 2025 FY | Jan 31, 2024 2023 FY | Jan 31, 2023 2022 FY | Jan 31, 2022 2021 FY | Jan 31, 2021 2020 FY | Jan 31, 2020 2019 FY | Jan 31, 2019 2018 FY | Jan 31, 2018 2017 FY | Jan 31, 2017 2016 FY | Jan 31, 2016 2015 FY | Jan 31, 2015 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
477.11 | 324.79 | 270.78 | 170.26 | 112.95 | 149.92 | 132.36 | 95.86 | 70.37 | 54.40 | 34.74 | 22.76 |
|
基本每股收益
|
2.50 | 1.11 | 0.65 | -0.31 | -0.53 | 0.12 | 0.59 | 1.20 | 0.79 | 0.45 | 0.29 | 0.39 |
|
稀释每股收益
|
2.46 | 1.09 | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 | 1.17 | 0.77 | 0.44 | 0.28 | 0.21 |
|
加权平均股数
|
86.13 | 86.87 | 85.56 | 84.44 | 83.13 | 74.24 | 67.03 | 61.84 | 60.30 | 58.62 | 56.72 | 31.18 |
|
稀释加权平均股数
|
87.47 | 88.83 | 86.96 | 84.44 | 83.13 | 75.68 | 68.45 | 63.37 | 61.85 | 59.89 | 58.86 | 51.86 |
|
综合收益
|
209.49 | 96.70 | 55.71 | -26.14 | -44.29 | - | 39.66 | 73.90 | 47.30 | 26.31 | 16.52 | 10.17 |